Suchergebnisse - "Xu, Binghe"

PubPharm (70)

1

Clinicopathological and survival analysis of primary spindle cell carcinoma of the breast in Chinese patients

enthalten in: American journal of cancer research | 2024

von Qian, X. | Xiao, M. | Liu, Y. | +6

2

Pharmacokinetics, safety, and antitumor activity of talazoparib monotherapy in Chinese patients with advanced solid tumors

enthalten in: Investigational new drugs | 2023

von Luo, Y. | Cheng, Y. | Wu, C. | +5

3

Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): final analysis of a phase III, randomized, double-blind, placebo-controlled study

enthalten in: Breast cancer research and treatment | 2022

von Xu, B. | Li, W. | Zhang, Q. | +11

4

Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study

enthalten in: Breast cancer research and treatment | 2022

von Xu, B. | Sun, T. | Shi, Y. | +22

5

Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

enthalten in: Breast cancer research and treatment | 2022

von Wu, Y. | Han, Y. | Li, Q. | +12

6

The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study

enthalten in: International journal of clinical oncology | 2022

von Han, Y. | Wu, Y. | Xu, H. | +2

7

Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up

enthalten in: Breast cancer research and treatment | 2021

von Zheng, F. | Du, F. | Wang, W. | +14

8

Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer

enthalten in: Targeted oncology | 2021

von Wang, J. | Zhang, Q. | Li, Q. | +14

9

Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial

enthalten in: Breast cancer research and treatment | 2021

von Wang, Z. | Liu, J. | Ma, F. | +8

10

Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women

enthalten in: Cancer chemotherapy and pharmacology | 2021

von Xu, B. | Li, H. | Zhang, Q. | +12

1
2
3
4
5
6
7
Nächster »
[7]